La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Shanghai Haohai Biological Technology Gestion
Gestion contrôle des critères 4/4
Le PDG Shanghai Haohai Biological Technology's est Jianying Wu, nommé en Jul2010, a un mandat de 14.08 ans. détient directement 4.76% des actions de la société, d'une valeur de HK$ 658.30M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 9.7 ans et 10.8 ans.
Informations clés
Jianying Wu
Directeur général
CN¥1.9m
Rémunération totale
| Pourcentage du salaire du PDG | n/a |
| Durée du mandat du directeur général | 14.1yrs |
| Propriété du PDG | 3.7% |
| Durée moyenne d'occupation des postes de direction | 9.7yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 10.8yrs |
Mises à jour récentes de la gestion
Recent updates
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25
Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All
May 22Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price
May 08Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Apr 19Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Mar 04Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 03Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?
Jan 10Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Oct 08Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly
Jul 07Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%
May 27These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Apr 04Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%
Mar 16Can Mixed Fundamentals Have A Negative Impact on Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Current Share Price Momentum?
Feb 23What Type Of Shareholders Own The Most Number of Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Shares?
Feb 05
Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | CN¥432m |
| Dec 31 2023 | CN¥2m | n/a | CN¥416m |
| Sep 30 2023 | n/a | n/a | CN¥346m |
| Jun 30 2023 | n/a | n/a | CN¥315m |
| Mar 31 2023 | n/a | n/a | CN¥226m |
| Dec 31 2022 | CN¥2m | CN¥855k | CN¥180m |
| Sep 30 2022 | n/a | n/a | CN¥203m |
| Jun 30 2022 | n/a | n/a | CN¥192m |
| Mar 31 2022 | n/a | n/a | CN¥272m |
| Dec 31 2021 | CN¥1m | CN¥845k | CN¥352m |
| Sep 30 2021 | n/a | n/a | CN¥428m |
| Jun 30 2021 | n/a | n/a | CN¥434m |
| Mar 31 2021 | n/a | n/a | CN¥370m |
| Dec 31 2020 | CN¥1m | CN¥768k | CN¥230m |
| Sep 30 2020 | n/a | n/a | CN¥232m |
| Jun 30 2020 | n/a | n/a | CN¥216m |
| Mar 31 2020 | n/a | n/a | CN¥279m |
| Dec 31 2019 | CN¥2m | CN¥742k | CN¥371m |
| Sep 30 2019 | n/a | n/a | CN¥353m |
| Jun 30 2019 | n/a | n/a | CN¥386m |
| Mar 31 2019 | n/a | n/a | CN¥375m |
| Dec 31 2018 | CN¥1m | CN¥712k | CN¥415m |
| Sep 30 2018 | n/a | n/a | CN¥411m |
| Jun 30 2018 | n/a | n/a | CN¥408m |
| Mar 31 2018 | n/a | n/a | CN¥390m |
| Dec 31 2017 | CN¥1m | CN¥583k | CN¥372m |
Rémunération vs marché: La rémunération totale de Jianying ($USD 267.02K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 588.16K ).
Rémunération et revenus: La rémunération de Jianying a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Jianying Wu (60 yo)
14.1yrs
Titularisation
CN¥1,904,800
Compensation
Dr. Jianying Wu has been General Manager of Shanghai Haohai Biological Technology Co., Ltd. since July 23, 2010 and has been its Executive Director since December 2014. Mr. Wu served as a Director at Shang...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman | 14.1yrs | CN¥1.89m | 3.64% CN¥ 499.6m | |
| GM & Executive Director | 14.1yrs | CN¥1.90m | 3.68% CN¥ 504.8m | |
| CFO & Executive Director | 7.7yrs | CN¥1.45m | 0.036% CN¥ 5.0m | |
| Executive Director | 9.7yrs | CN¥1.26m | 0.26% CN¥ 35.3m | |
| Joint Company Secretary | 4.7yrs | CN¥868.70k | 0.0044% CN¥ 606.0k | |
| Deputy General Manager | 9.9yrs | CN¥912.50k | 0.012% CN¥ 1.6m | |
| Joint Company Secretary | 9.8yrs | pas de données | pas de données |
9.7yrs
Durée moyenne de l'emploi
49yo
Âge moyen
Gestion expérimentée: L'équipe de direction de 6826 est chevronnée et expérimentée (ancienneté moyenne 9.7 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman | 14.1yrs | CN¥1.89m | 3.64% CN¥ 499.6m | |
| GM & Executive Director | 14.1yrs | CN¥1.90m | 3.68% CN¥ 504.8m | |
| CFO & Executive Director | 7.5yrs | CN¥1.45m | 0.036% CN¥ 5.0m | |
| Executive Director | 14.1yrs | CN¥1.26m | 0.26% CN¥ 35.3m | |
| Independent Non-Executive Director | less than a year | pas de données | pas de données | |
| Non Executive Director | 14.1yrs | pas de données | 17.47% CN¥ 2.4b | |
| Non-Executive Director | 14.1yrs | CN¥150.00k | 1.21% CN¥ 166.4m | |
| Chairman of the Supervisory Committee | 14.1yrs | pas de données | 1.21% CN¥ 166.4m | |
| Independent Non-Executive Director | 4.2yrs | CN¥150.00k | pas de données | |
| Independent Non-Executive Director | 4.2yrs | CN¥150.00k | pas de données | |
| Independent Non-Executive Director | 4.2yrs | CN¥150.00k | pas de données | |
| Independent Non-Executive Director | 4.2yrs | CN¥150.00k | pas de données |
10.8yrs
Durée moyenne de l'emploi
52.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration 6826 sont chevronnés et expérimentés (durée moyenne d'administration 10.8 ans).